Lord Abbett Micro Cap Growth I holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.
Lord Abbett Micro Cap Growth Fund Class I LMIYX
- NAV / 1-Day Return 28.93 / −0.21 %
- Total Assets 198.5M
-
Adj. Expense Ratio
1.120%
- Expense Ratio 1.120%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1M
- Status Limited
- TTM Yield 0.01%
- Turnover 107%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0
Morningstar’s Analysis LMIYX
Will LMIYX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Cogent Biosciences Inc | 2.80 | 6M | Healthcare |
Forte Biosciences Inc Ordinary Shares | 2.70 | 6M | Healthcare |
Adaptive Biotechnologies Corp | 2.67 | 6M | Healthcare |
Aehr Test Systems | 2.65 | 6M | Technology |
Navan Inc Ordinary Shares - Class A | 2.59 | 5M | Technology |
Enliven Therapeutics Inc | 2.39 | 5M | Healthcare |
Lindblad Expeditions Holdings Inc | 2.16 | 5M | Consumer Cyclical |
CECO Environmental Corp | 2.03 | 4M | Industrials |
10x Genomics Inc Ordinary Shares - Class A | 2.02 | 4M | Healthcare |
Pattern Group Inc Ordinary Shares - Series A | 1.90 | 4M | Consumer Cyclical |